
Pioglitazone, quercetin and hydroxy citric acid effect on hepatic biomarkers in Non Alcoholic Steatohepatitis
Author(s) -
Krishna Mohan Surapaneni,
Mallika Jainu
Publication year - 2014
Publication title -
pharmacognosy research
Language(s) - English
Resource type - Journals
eISSN - 0976-4836
pISSN - 0974-8490
DOI - 10.4103/0974-8490.129037
Subject(s) - steatohepatitis , pioglitazone , medicine , albumin , alkaline phosphatase , gastroenterology , creatinine , lactate dehydrogenase , fatty liver , aspartate transaminase , alanine transaminase , liver function tests , bilirubin , endocrinology , chemistry , biochemistry , diabetes mellitus , disease , type 2 diabetes , enzyme
Non alcoholic steatohepatitis (NASH), severe form of diseases belonging to the spectrum of the Non alcoholic fatty liver disease (NAFLD). It is an asymptomatic disease which leads to fibrosis and finally to cirrhosis, an end stage liver disease.